The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.
Merilog’s approval comes as the insulin space has over the past year suffered several setbacks, including strong calls for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback